MAPK1 and gastric cancer: MAPK1–109aa inhibits the phosphorylation of MAPK1 by competitively binding MEK1, thereby inhibiting the activation of the MAPK1 pathway and its downstream factors and showing the ability to inhibit the proliferation and invasion of GC cells.